Literature DB >> 25592124

Outcomes following cataract surgery in choroideremia.

T L Edwards1, M Groppe1, R E MacLaren2.   

Abstract

PurposeTo present a case series of cataract surgery outcomes in choroideremia eyes with an emphasis on the safety of this common operation in advanced stages of the disease.MethodsA single centre retrospective interventional case series comprising six patients with varying degrees of visual loss secondary to choroideremia underwent cataract surgery at a single tertiary eye hospital. Pre- and post-operative best-corrected Snellen visual acuity, spectral domain optical coherence tomography (SD-OCT), and slit lamp examination were performed together with fundus autofluorescence (FAF) and colour fundus photographs.The prevalence of intra- or post-operative complications, post-operative visual outcome, and change in central macular thickness were recorded.ResultsThe pre-operative best-corrected Snellen visual acuity in the operated eyes ranged from 6/12 (20/40) to PL. All but one patient had either an objective or a subjective improvement in visual acuity. There was no evidence of retinal phototoxicity or post-operative cystoid macular oedema (CMO). Three patients developed early capsular fibrosis.ConclusionsAlthough the residual functioning retina in choroideremia patients may be potentially vulnerable, this report finds no evidence of iatrogenic vision loss after uncomplicated cataract surgery. This suggests that cataract surgery may be performed safely in choroideremia patients, although a guarded prognosis for visual improvement should be emphasized in the informed consent.

Entities:  

Mesh:

Year:  2015        PMID: 25592124      PMCID: PMC4816357          DOI: 10.1038/eye.2014.326

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  25 in total

Review 1.  Coats, tethers, Rabs, and SNAREs work together to mediate the intracellular destination of a transport vesicle.

Authors:  Huaqing Cai; Karin Reinisch; Susan Ferro-Novick
Journal:  Dev Cell       Date:  2007-05       Impact factor: 12.270

2.  Clinical findings in a choroideremia patient who underwent vitrectomy for retinal detachment associated with macular hole.

Authors:  Hajime Shinoda; Takashi Koto; Keiko Fujiki; Akira Murakami; Kazuo Tsubota; Yoko Ozawa
Journal:  Jpn J Ophthalmol       Date:  2011-03-13       Impact factor: 2.447

3.  Incidence, risk factors, and morphology in operating microscope light retinopathy.

Authors:  S G Khwarg; F A Linstone; S A Daniels; S J Isenberg; T A Hanscom; M Geoghegan; B R Straatsma
Journal:  Am J Ophthalmol       Date:  1987-03-15       Impact factor: 5.258

4.  Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants.

Authors:  Paul A Sieving; Rafael C Caruso; Weng Tao; Hanna R Coleman; Darby J S Thompson; Keri R Fullmer; Ronald A Bush
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

5.  Cataract extraction outcomes and the prevalence of zonular insufficiency in retinitis pigmentosa.

Authors:  Mark Samuel Dikopf; Clement Chikai Chow; William Francis Mieler; Elmer Yuchen Tu
Journal:  Am J Ophthalmol       Date:  2013-04-28       Impact factor: 5.258

6.  Cataract in retinitis pigmentosa. An analysis of cataract surgery results and pathological lens changes.

Authors:  P P Fagerholm; B T Philipson
Journal:  Acta Ophthalmol (Copenh)       Date:  1985-02

7.  Macular hole surgery in patients with end-stage choroideremia.

Authors:  Martin S Zinkernagel; Markus Groppe; Robert E MacLaren
Journal:  Ophthalmology       Date:  2013-04-04       Impact factor: 12.079

8.  Cataract extraction and intraocular lens implantation in patients with retinitis pigmentosa or Usher's syndrome.

Authors:  D A Newsome; W J Stark; I H Maumenee
Journal:  Arch Ophthalmol       Date:  1986-06

9.  Rapid anterior capsular contraction after phacoemulsification surgery in a patient with retinitis pigmentosa.

Authors:  Tan Jin-Poi; Ismail Shatriah; Sonny Teo Khairy-Shamel; Embong Zunaina
Journal:  Clin Ophthalmol       Date:  2013-05-06

10.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.

Authors:  Robert E MacLaren; Markus Groppe; Alun R Barnard; Charles L Cottriall; Tanya Tolmachova; Len Seymour; K Reed Clark; Matthew J During; Frans P M Cremers; Graeme C M Black; Andrew J Lotery; Susan M Downes; Andrew R Webster; Miguel C Seabra
Journal:  Lancet       Date:  2014-01-16       Impact factor: 79.321

View more
  1 in total

1.  Pathogenic mechanisms and the prospect of gene therapy for choroideremia.

Authors:  Ioannis S Dimopoulos; Stephanie Chan; Robert E MacLaren; Ian M MacDonald
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-01       Impact factor: 0.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.